How to drive payer submission readiness for your late-phase products

The PRMA Healthcheck® digital assessments of late-phase pharmaceutical assets help you to bring a clear understanding of the risks and opportunities in multiple markets based on current payer requirements.

This collection of case studies from leading pharmaceutical manufacturers explains how the PRMA Healthcheck® helps organizations to:

  • focus attention on the key issues that will impact outcomes of payer assessments

  • determine actions to mitigate the risks of not meeting payer expectations

  • identify clear responsibilities across global, regional, and affiliate teams for implementation of payer-focused activities

  • accelerate successful HTA submission and payer evaluation readiness by producing high-quality payer focused evidence that is driven by informed organizational collaboration.

FREE eBook

Drive readiness for payer submissions for your Phase 2 and 3 products

Free download

Latest insights

Market access for biotechnology

Menopause and work: initiatives to support employees

LGBTQ+ History Month in the workplace